Aspira Women's Health Inc
NASDAQ:AWH
Intrinsic Value
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. [ Read More ]
The intrinsic value of one AWH stock under the Base Case scenario is 10.97 USD. Compared to the current market price of 3.49 USD, Aspira Women's Health Inc is Undervalued by 68%.
Valuation Backtest
Aspira Women's Health Inc
Run backtest to discover the historical profit from buying and selling AWH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Aspira Women's Health Inc
Current Assets | 5.3m |
Cash & Short-Term Investments | 2.6m |
Receivables | 1.5m |
Other Current Assets | 1.2m |
Non-Current Assets | 982k |
PP&E | 693k |
Other Non-Current Assets | 289k |
Current Liabilities | 5.1m |
Accounts Payable | 1.3m |
Accrued Liabilities | 3m |
Short-Term Debt | 670k |
Other Current Liabilities | 166k |
Non-Current Liabilities | 3.5m |
Long-Term Debt | 1.4m |
Other Non-Current Liabilities | 2.1m |
Earnings Waterfall
Aspira Women's Health Inc
Revenue
|
9.2m
USD
|
Cost of Revenue
|
-3.9m
USD
|
Gross Profit
|
5.3m
USD
|
Operating Expenses
|
-24.1m
USD
|
Operating Income
|
-18.9m
USD
|
Other Expenses
|
2.2m
USD
|
Net Income
|
-16.7m
USD
|
Free Cash Flow Analysis
Aspira Women's Health Inc
What is Free Cash Flow?
AWH Profitability Score
Profitability Due Diligence
Aspira Women's Health Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Aspira Women's Health Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
AWH Solvency Score
Solvency Due Diligence
Aspira Women's Health Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Score
Aspira Women's Health Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AWH Price Targets Summary
Aspira Women's Health Inc
According to Wall Street analysts, the average 1-year price target for AWH is 5.36 USD with a low forecast of 3.33 USD and a high forecast of 7.56 USD.
Ownership
AWH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AWH Price
Aspira Women's Health Inc
Average Annual Return | 120.93% |
Standard Deviation of Annual Returns | 369.17% |
Max Drawdown | -98% |
Market Capitalization | 37.2m USD |
Shares Outstanding | 10 336 800 |
Percentage of Shares Shorted | 1.5% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 106 full-time employees. The company went IPO on 2000-09-29. Its products include OVA1 and Overa, OVA1plus, Aspira GenetiX and Aspira Synergy. OVA1 is a blood test that is intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical, and Overa is intended to maintain OVA1’s high sensitivity. OVA1plus is a reflex test performed for those OVA1 test results that are in the intermediate risk range. Aspira GenetiX is a genetic test for gynecologic cancer risk, with a focus on female reproductive cancers, including breast, ovarian, endometrial, uterine and cervical cancers. Aspira Synergy is an en-suite, cloud-based technology transfer solution that provides an end-to-end solution from specimen collection to a customized white-label report for clinical laboratories to internalize testing of its products.
Contact
IPO
Employees
Officers
The intrinsic value of one AWH stock under the Base Case scenario is 10.97 USD.
Compared to the current market price of 3.49 USD, Aspira Women's Health Inc is Undervalued by 68%.